Blerone Xl 2mg Prolonged Release Capsules
Out of date information, search anotherPARTICULARS TO APPEAR ON THE OUTER PACKAGING
OUTER PACKING/ BLISTER
1. NAME OF THE MEDICINAL PRODUCT
Blerone XL 2 mg prolonged-release capsules Tolterodine tartrate
2. STATEMENT OF ACTIVE SUBSTANCE(S)
Each capsule contains 2 mg of tolterodine tartrate, which is equivalent to 1.37 mg of tolterodine.
3. LIST OF EXCIPIENTS
Also contains lactose and sodium
4. PHARMACEUTICAL FORM AND CONTENTS
Prolonged-release hard capsules Pack sizes:
|
UK/H/4752/01/DC | |
|
14 hard capsules 28 hard capsules 84 hard capsules | |
5. METHOD AND ROUTE(S) OF ADMINISTRATION
Oral use.
Read the package leaflet before use.
6. SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN
Keep out of the sight and reach of children.
7. OTHER SPECIAL WARNING(S), IF NECESSARY
8. EXPIRY DATE
EXP
9. SPECIAL STORAGE CONDITIONS
10. SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE
11. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
Zentiva, One Onslow Street, Guildford, Surrey, GU1 4YS, UK
12. MARKETING AUTHORISATION NUMBER(S)
PL17780/0628
13. BATCH NUMBER
Lot
14. GENERAL CLASSIFICATION FOR SUPPLY
POM
15. INSTRUCTIONS ON USE
16. INFORMATION IN BRAILLE
Blerone XL 2 mg capsules
1. NAME OF THE MEDICINAL PRODUCT
Blerone XL 2 mg prolonged-release capsules Tolterodine Tartrate
2. NAME OF THE MARKETING AUTHORISATION HOLDER
Zentiva
3. EXPIRY DATE
EXP
Shelf life: 24 months
4. BATCH NUMBER
Lot
5. OTHER
1. NAME OF THE MEDICINAL PRODUCT
Blerone XL 2 mg prolonged-release capsules Tolterodine tartrate
2. STATEMENT OF ACTIVE SUBSTANCE(S)
Each capsule contains 2 mg of tolterodine tartrate, which is equivalent to 1,37mg of tolterodine
3. LIST OF EXCIPIENTS
Also contains lactose and sodium
4. PHARMACEUTICAL FORM AND CONTENTS
30 hard capsules 100 hard capsules 200 hard capsules
5. METHOD AND ROUTE(S) OF ADMINISTRATION
Oral use.
Read the package leaflet before use.
6. SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
Keep out of the reach and sight of children.
7. OTHER SPECIAL WARNING(S), IF NECESSARY
8. EXPIRY DATE
EXP
HDPE bottle: Shelf life after first opening is 200 days
9. SPECIAL STORAGE CONDITIONS
Do not store above 25°C.
10. SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE
11. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
Zentiva, One Onslow Street, Guildford, Surrey, GU1 4YS, UK
12. MARKETING AUTHORISATION NUMBER(S)
PL17780/0628
13. BATCH NUMBER
Lot
14. GENERAL CLASSIFICATION FOR SUPPLY
POM
15. INSTRUCTIONS ON USE
16. INFORMATION IN BRAILLE
Blerone XL 2 mg capsules
1. NAME OF THE MEDICINAL PRODUCT
Blerone XL 2 mg prolonged-release capsules Tolterodine tartrate
2. STATEMENT OF ACTIVE SUBSTANCE(S)
Each capsule contains 2 mg of tolterodine tartrate, which is equivalent to 1,37mg of tolterodine
3. LIST OF EXCIPIENTS
Also contains lactose and sodium
4. PHARMACEUTICAL FORM AND CONTENTS
30 hard capsules 100 hard capsules 200 hard capsules
5. METHOD AND ROUTE(S) OF ADMINISTRATION
Oral use.
Read the package leaflet before use.
6. SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE REACH AND SIGHT OF CHILDREN
Keep out of the reach and sight of children.
7. OTHER SPECIAL WARNING(S), IF NECESSARY
8. EXPIRY DATE
EXP
Shelf life after first opening is 200 days
9. SPECIAL STORAGE CONDITIONS
Do not store above 25°C.
10. SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE
11. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
Zentiva, One Onslow Street, Guildford, Surrey, GU1 4YS, UK
12. MARKETING AUTHORISATION NUMBER(S)
PL17780/0628
13. BATCH NUMBER
Lot
14. GENERAL CLASSIFICATION FOR SUPPLY
POM
15. INSTRUCTIONS ON USE
16. INFORMATION IN BRAILLE
Blerone XL 2 mg capsules
7